Profile

SFH Oxford Ltd

Since initial investment by UKI2S in 2013, the SFH team based at the Harwell Campus has been developing Graducheck, a sensor-based technology for improving the application of compression bandages for treatment of venous leg ulcers – a chronic wound that is a considerable burden; both for the patients and national healthcare systems. Venous leg ulcers affect over 12.5m patients globally and SFH Oxford’s application aims to massively increase the treatment efficiency.

Status current

Associated Fund UK Innovation & Science Seed Fund

Sector Medical / Biotechnology

Website www.sfhoxford.com/

Associated Team Members

More Companies in Medical / Biotechnology

Your browser is out-of-date!

Update your browser to view this website correctly.Update my browser now

×